PREMIXED INSULIN REGIMEN TO BASAL-BOLUS INSULIN OUTCOMES IN TYPE 2 DIABETES SUBJECTS. International Research Journal of Pharmacy, [S. l.], v. 14, n. 2, p. 40–48, 2023. DOI: 10.56802/enp5vh61. Disponível em: https://irjponline.org/index.php/irjp/article/view/3470. Acesso em: 27 jul. 2026.